Clinical Studies

At 1858 performance medicine we want our patients to be well educated and informed before making the decision to take Hormone Replacement Therapy. All primary care physicians (PCP) are not treating low Testosterone level patients by educating all patients to ensure they understand the process they will undergo during therapy. For that reason, we want to provide you with some resources that we utilize to educate our patients in making educated decisions. We hope that by providing our patients with as many resources as possible that our patients feel, not only more at ease with choosing hormone replacement therapy, but also more at ease with choosing 1858 performance medicine.

• Testosterone Therapy in Men With Hypogonadism Prevents Progression From Prediabetes to Type 2 Diabetes

• Long-Term Testosterone Therapy Improves Cardiometabolic Function and Reduces Risk of Cardiovascular Disease in Men with Hypogonadism

• Long-Term Testosterone Treatment in elderly men with hypogonadism and erectile dysfunction reduces obesity parameters and improves metabolic syndrome.

• Long-Term Testosterone Therapy in Type 2 Diabetes Is Associated with Decreasing Waist Circumference and Improving Erectile Function

• Testosterone treatment and the risk of aggressive prostate cancer in men with low testosterone levels

• Muscle and strength gains during testosterone therapy are greater with testosterone injections than gels

• Hypogonadism, Muscle Weakness, and Multi-morbidity Men

• Clinical practice guidelines on diagnosis and treatment of hypogonadism – important issues

• Pennsylvania researchers find benefits to testosterone treatments

• Stem Cell Therapy

• Testosterone therapy does not raise prostate cancer risk